Evidence map›Paper›PMID 25678086›Full record

ArticleThe Journal of allergy and clinical immunology2015

Rare variants at 16p11.2 are associated with common variable immunodeficiency.

S Melkorka Maggadottir, Jin Li, Joseph T Glessner, Yun Rose Li, Zhi Wei, Xiao Chang, Frank D Mentch, Kelly A Thomas, Cecilia E Kim, Yan Zhao and 10 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Journal of allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Advances in clinical immunology in 2015.The Journal of allergy and clinical immunology · 2016
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

S Melkorka MaggadottirDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa; Center for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Jin LiCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Joseph T GlessnerCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Yun Rose LiCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa; Medical Scientist Training Program, Perelman School of Medicine Philadelphia, University of Pennsylvania, Philadelphia, Pa.
Zhi WeiDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ.
Xiao ChangCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Frank D MentchCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Kelly A ThomasCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Cecilia E KimCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Yan ZhaoCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Cuiping HouCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Fengxiang WangCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa.
Silje F JørgensenK.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Elena E PerezDivision of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of South Florida, St Petersburg, Fla.
Kathleen E SullivanDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Jordan S OrangeSection of Immunology, Allergy and Rheumatology, Texas Children's Hospital, Houston, Tex.
Tom H KarlsenK.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Helen ChapelNuffield Department of Medicine, University of Oxford and Oxford Radcliffe Hospital, Oxford, United Kingdom.
Charlotte Cunningham-RundlesInstitute of Immunology and Department of Medicine, Mount Sinai School of Medicine, New York, NY.
Hakon HakonarsonCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine Philadelphia, University of Pennsylvania, Philadelphia, Pa. Electronic address: Hakonarson@email.chop.edu.
Children's Hospital of Philadelphia · USOslo University Hospital · NOIcahn School of Medicine at Mount Sinai · USJohn Radcliffe Hospital · GBNew Jersey Institute of Technology · USTexas Children's Hospital · USUniversity of South Florida St. Petersburg · US

Funding

Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
Resources to Assist Investigations in Primary Immunodeficiency Diseases (U24)U24AI086037 · NIAID · IMMUNE DEFICIENCY FOUNDATION · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2010 to 2019
$6.5M
TARGETING PRIMARY IMMUNODEFICIENCY AMONG MINORITIESR18AI048693 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2000 to 2016
$6.2M
Integrative Analysis of a GWAS Repository with EMRs from over 40,000 ChildrenU01HG006830 · NHGRI · CHILDREN'S HOSP OF PHILADELPHIA · PI HAKONARSON, HAKON · 2012 to 2014
$3.7M
NHGRI NIH HHS U01 HG006830NHGRI NIH HHS U01HG006830NIAID NIH HHS P01 AI061093NIAID NIH HHS R18 AI048693NIAID NIH HHS U24 AI086037
6 · The paper itself

Abstract

backgroundCommon variable immunodeficiency (CVID) is characterized clinically by inadequate quantity and quality of serum immunoglobulins with increased susceptibility to infections, resulting in significant morbidity and mortality. Only a few genes have been uncovered, and the genetic background of CVID remains elusive to date for the majority of patients.

objectiveWe sought to seek novel associations of genes and genetic variants with CVID.

methodsWe performed association analyses in a discovery cohort of 164 patients with CVID and 19,542 healthy control subjects genotyped on the Immuno BeadChip from Illumina platform; replication of findings was examined in an independent cohort of 135 patients with CVID and 2,066 healthy control subjects, followed by meta-analysis.

resultsWe identified 11 single nucleotide polymorphisms (SNPs) at the 16p11.2 locus associated with CVID at a genome-wide significant level in the discovery cohort. The most significant SNP, rs929867 (P = 6.21 × 10(-9)), is in the gene fused-in-sarcoma (FUS), with 4 other SNPs mapping to integrin CD11b (ITGAM). Results were confirmed in our replication cohort. Conditional association analysis suggests a single association signal at the 16p11.2 locus. A strong trend of association was also seen for 38 SNPs (P < 5 × 10(-5)) in the MHC region, supporting that this is a genuine CVID locus. Interestingly, we found that 80% of patients with the rare ITGAM variants have reduced switched memory B-cell counts.

conclusionWe report a novel association of CVID with rare variants at the FUS/ITGAM (CD11b) locus on 16p11.2. The association signal is enriched for promoter/enhancer markers in the ITGAM gene. ITGAM encodes the integrin CD11b, a part of complement receptor 3, a novel candidate gene implicated here for the first time in the pathogenesis of CVID.

Indexed as

Chromosomes, Human, Pair 16Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultB-LymphocytesCase-Control StudiesCD11b AntigenChild, PreschoolCohort StudiesCommon Variable ImmunodeficiencyEnhancer Elements, GeneticFemaleGenetic LociHumansImmunologic MemoryLinkage DisequilibriumCD11b AntigenFUS protein, humanITGAM protein, humanRNA-Binding Protein FUSgenome-wide association studyImmunodeficiencyimmunogeneticsITGAMrare variants

Identifiers

PMID25678086
PMCPMC4461447
OpenAlexW2104419416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.